CardioPolymers (formerly Symphony Medical) of Laguna Hills, Calif., is developing a medical device to reverse CHF in patients who an enlarged left ventricle as a result of mitral valve regurgitation, ischemia, dilated cardiomyopathy and/or other disorders.
Cardiogenesis, a medical device company that develops tools for the treatment of ischemic cardiac disease, has helped numerous heart-disease patients with the use of laser therapy.
The Newton, Mass.-based biopharmaceutical company is developing a small-molecule drug for sickle cell disease.
The San Diego-based company seeks to improve upon existing cancer therapeutics with its reformulations of the chemotherapy drugs Navelbine and Taxotere.
Hospital-acquired infections (HAIs) are one of the biggest health hazards facing hospitals today.
An estimated 2.85 billion people worldwide were at risk of contracting malaria in 2009, according to a new report published Tuesday in the journal PLos Neglected Tropical Diseases.
Doctors in London successfully used a genetically engineered version of the herpes virus to treat head and neck cancer in a small clinical trial of 17 patients.
More Americans are getting tested for colon cancer and breast cancer, the U.S. Centers for Disease Control (CDC) recently reported, but the numbers still aren’t high enough.
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
Copyright © 2025 | WordPress Theme by MH Themes